What Is Quality by Design and Why It Matters in PharmaUntitledA Science-Based Route to Consistent Quality
Quality by Design Training in Zimbabwe equips pharmaceutical professionals to build quality into a product from the design stage rather than testing it in at the end. Quality by Design (QbD) is a systematic, science-based approach to drug product and process development, set out in the ICH Q8, Q9, Q10 and Q11 guidelines and increasingly expected under the WHO-aligned GMP standards enforced by the Medicines Control Authority of Zimbabwe (MCAZ). Over one practical day, you learn to apply the core QbD toolkit: the Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), risk assessment with Ishikawa diagrams and FMEA, Design of Experiments (DoE), the design space and the control strategy. Each concept is reinforced with realistic development scenarios drawn from small molecule and biologic products. The programme suits formulation scientists, process development engineers, analytical chemists, quality assurance teams and regulatory affairs specialists across Zimbabwe's manufacturers, CDMOs and API sites. As local production and export ambitions grow, professionals who can design robust processes and defend them in submissions are in real demand. Start your QbD journey with Invensis Learning.










